How fast does Mounjaro kick in — and what should you feel first?

Tirzepatide reaches detectable blood levels within 24 hours of a dose and reaches a steady state after roughly four weeks of weekly injections.
Appetite changes and early fullness signals are often the first thing people notice, sometimes within days of the first injection.
Weight loss builds across months: the clinical trial results cited by NICE reflect outcomes at 72 weeks, not four weeks.
The starter dose (2.5 mg) is there to help your body adjust to the medicine — significant appetite suppression typically increases with each titration step.

Mounjaro typically begins working within the first week, though the effects build gradually over months. Most people notice some reduction in appetite during the first pen, but meaningful weight change usually becomes visible by weeks four to eight. These are prescription-only medicines; a prescriber assesses whether they're clinically right for you before treatment starts. The timeline below follows what actually happens, dose by dose, so you know what to expect rather than wondering whether it's working.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

A practical timeline: what happens week by week on Mounjaro

Step 1, the first pen: days one to twenty-eight

The first pen contains four weekly doses, all at 2.5 mg. That dose exists for one reason: tolerance. Your digestive system needs time to adapt to tirzepatide's effect on gastric emptying, and starting low reduces the nausea and stomach discomfort that higher doses can cause from day one. Some people feel a noticeable dip in appetite within the first few days. Others notice nothing dramatic for the first fortnight. Both are normal.

Pharmacokinetically, tirzepatide's half-life is around five days, so after your first injection it takes about four weeks of weekly doses before levels plateau in your system. That plateau (the "steady state") is when the medicine is working as consistently as it will at that dose. You can find a clear overview of how tirzepatide acts in the body on the NHS and clinical guidance we've summarised here.

Practically: your pen arrives in a plain, unbranded box via DPD, tracked to your door. It goes straight into the fridge. The KwikPen itself is pre-filled, no mixing, no measuring. Most people inject into the abdomen or thigh; the pen does the rest. If you're curious about how quickly Mounjaro begins to have an effect after that first injection, we cover the early signs in detail. Don't judge the medicine by week one.

Step 2, titration weeks: the five to twelve range

After four weeks your prescriber typically moves you to 5 mg. This is where most people report the first unmistakeable shift: a quietening of the background noise of hunger, smaller portions feeling satisfying, less interest in snacking in the evening. These effects come from tirzepatide's dual action on GIP and GLP-1 receptors, slowing how quickly the stomach empties and signalling fullness to the brain more effectively than either pathway does alone. It is the only medicine licensed in the UK that works through both receptor types simultaneously.

Weight change during this phase tends to be modest on the scales but significant in lived experience: people eat less without fighting themselves to do it. The full Mounjaro treatment page covers the complete titration schedule and what each stage is designed to do. A useful companion read is our piece on how long it takes before the medicine fully kicks in, which goes deeper on what "working" actually means at different stages.

Side effects tend to peak around dose increases and ease off within one to two weeks. Nausea, loose stools and fatigue are the most common. Staying hydrated and eating smaller, lower-fat meals during this phase helps considerably.

Step 3, months three to six: when results become measurable

This is the phase where the scales catch up with the appetite changes. Clinical trial data published in the SURMOUNT-1 trial in the New England Journal of Medicine showed average body-weight reductions of around 20–21% at the 15 mg maintenance dose over 72 weeks. Those results don't land in month one, they accumulate. At the six-month point, participants on the higher doses in SURMOUNT-1 had typically lost somewhere between 10% and 15% of starting body weight, reflecting steady progress rather than a sudden drop.

NICE, in its appraisal of tirzepatide (TA1026), notes that treatment should be reviewed if less than 5% weight loss has occurred after six months at the highest tolerated dose. That threshold is a clinical checkpoint, not a failure, it simply guides whether continuing makes sense for a given person. Prescribers at nume review this as part of every repeat consultation.

If you're thinking about the cost of reaching this stage, our Mounjaro cost page sets out what private treatment typically involves across several months, with honest context about what different price points do and don't include.

Step 4, maintenance: what long-term use looks like

Most people reach their maintenance dose somewhere between months three and six. At that point the focus shifts from titration to consistency: weekly injections at the same dose, regular clinical reviews, and the dietary and activity habits that support the medicine's effects. Weight loss continues to accumulate at maintenance dose, just more slowly than during the titration phase.

One thing our prescribers hear regularly: people who expected dramatic early results and nearly gave up by week six, who then saw the real shift between months two and four. Our guide on how long Mounjaro takes to kick in explains why the timeline unfolds the way it does, and what to expect at each stage. Understanding that the timeline is a process, not a switch, is probably the most useful thing this page can offer. If you have specific questions about your own situation, the FAQs section covers many common concerns, and our team is reachable via the contact page seven days a week.

Mounjaro is a prescription medicine. It's not assessed or licensed for rapid or cosmetic weight loss, and results vary between individuals. A prescriber decides whether it's appropriate for you based on your full clinical picture. If you'd like to understand whether you might be eligible, you can check your eligibility through a free consultation with our clinical team.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions